A hallmark feature of classical tumor suppressor genes such as BRCA1, BRCA2, and TP53 is their propensity to acquire loss‐of‐function point mutations that disrupt their tumor‐suppressive activities.[5] However, point mutations in the WWOX gene associated with functional loss of its tumor suppressor activity have rarely been identified to date. The gene discussed is TP53; the disease is neoplasm.